Heptavalent equine botulism antitoxin
Ended Purchase Order Awarded Last action
- Contract number
- W81XWH12P0321
- Awardee
-
Cangene Corporation UEI W1SXMKJPL8B5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $576,641
Award facts
- Opportunity
-
- W81XWH12T0262 Solicitation number
- Contract value 100% obligated
- $576,641.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Canada
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $576,641 |
Quick answers
Who was awarded contract W81XWH12P0321?
W81XWH12P0321 was awarded to Cangene Corporation by Medical Command (Department of the Army) on May 31, 2012.
How much is contract W81XWH12P0321 worth?
The government has obligated $576,641 on W81XWH12P0321.
Was contract W81XWH12P0321 competed?
The extent of competition for W81XWH12P0321 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award